Key facts
- Notable investors include Better Bite Ventures, Dao Foods.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Blue Canopy
- ·The full record, as it builds
Funding rounds
No funding rounds for Blue Canopy are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Blue Canopy
Developer of biomaterial and microbial protein intended for sustainable production purposes. The company offers fermentation process optimization, microbial protein development, mushroom-derived biomaterials with high chitin content, and applications in food additives and bio-feed, enabling the biotechnology market to access standardized processes, controlled material properties, and compliance with regulatory frameworks while supporting scalability, durability, and consistent output across multiple industrial applications.
- Sector
- Healthcare
- HQ
- Hangzhou, China
- Founded
- 2021
- Website
- bluecanopy.cn/
- Ownership
- Privately Held (backing)
Blue Canopy doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Blue Canopy shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Blue Canopy in its N-PORT filings yet. We sweep new filings monthly.